Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Simvastatin, Xenical, Nasacort Switch Decisions Imminent In New Zealand

This article was originally published in The Tan Sheet

Executive Summary

New Zealand's Ministry of Health is expected to issue a decision on behind-the-counter switches for simvastatin, Roche's Xenical and Aventis' Nasacort within four to six weeks
Advertisement

Related Content

Simvastatin in New Zealand
Simvastatin in New Zealand
Simvastatin in New Zealand
Non-Rx Zocor Will Be Available In UK Without Cholesterol Screen Requirement
Non-Rx Zocor Will Be Available In UK Without Cholesterol Screen Requirement

Topics

Advertisement
UsernamePublicRestriction

Register

PS096891

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel